Clinical Data Raises $47.4M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Clinical Data has raised gross proceeds of $47.4 million through the sale of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share.

According to a filing with the US Securities and Exchange Commission filed today, net proceeds from the offering are approximately $44.1 million. The underwriters of the offering have an option to purchase an additional 412,500 shares, which would bring total gross proceeds to $54.6 million. The offering is expected to close on Nov. 2, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.